In the last trading session, 0.26 million shares of the Virax Biolabs Group Ltd (NASDAQ:VRAX) were traded, and its beta was 1.68. Most recently the company’s share price was $2.18, and it changed around $0.04 or 1.87% from the last close, which brings the market valuation of the company to $9.46M. VRAX currently trades at a discount to its 52-week high of $9.00, offering almost -312.84% off that amount. The share price’s 52-week low was $0.60, which indicates that the current value has risen by an impressive 72.48% since then. We note from Virax Biolabs Group Ltd’s average daily trading volume that its 10-day average is 0.59 million shares, with the 3-month average coming to 1.88 million.

Virax Biolabs Group Ltd (NASDAQ:VRAX) trade information

Instantly VRAX has showed a green trend with a performance of 1.87% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.61 on recent trading dayincreased the stock’s daily price by 16.48%. The company’s shares are currently down -3.11% year-to-date, but still down -9.92% over the last five days. On the other hand, Virax Biolabs Group Ltd (NASDAQ:VRAX) is 41.56% up in the 30-day period. We can see from the shorts that 0.45 million shares have been sold at a short interest cover period of 0.11 day(s).

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -52.25%.

VRAX Dividends

Virax Biolabs Group Ltd’s next quarterly earnings report is expected to be released in February.

HRT FINANCIAL LP, with 1.2795% or 25672.0 shares worth $29000.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.